24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk

INTRODUCTION: To clarify the additional efficacy and safety benefits of 24 months’ treatment with the once-weekly formulation of teriparatide, which is currently used for 72 weeks. METHODS: This was a multicenter, open-label, single-arm study conducted in Japan. Subjects who were 65 years or older w...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Toshitsugu, Shiraki, Masataka, Fukunaga, Masao, Hagino, Hiroshi, Sone, Teruki, Nakano, Tetsuo, Kishimoto, Hideaki, Ito, Masako, Yoshikawa, Hideki, Kishida, Mitsukazu, Irie, Chika, Nakamura, Toshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504212/
https://www.ncbi.nlm.nih.gov/pubmed/28631217
http://dx.doi.org/10.1007/s12325-017-0568-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504212/
https://www.ncbi.nlm.nih.gov/pubmed/28631217
http://dx.doi.org/10.1007/s12325-017-0568-x

Ejemplares similares